These produce complete and partial response rates of 15 to 25 in patients with locoregional recurrence or distant metastases

مهمان عزیز شما حق دیدن لینک ها را ندارید برای استفاده از امکانات کامل انجمن عضو شوید

عضویت

Development of more specific biomarkers that predict therapeutic response to tamoxifen therapy is one of the major challenges for the successful treatment of breast cancer 1